查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1585658

生物製藥製造消耗品測試市場：按產品類型、類型、應用分類 - 全球預測 2025-2030

Biopharmaceuticals Manufacturing Consumables Testing Market by Product Type (Consumables, Instruments, Services), Type (Compendial Testing, Custom Testing, Laboratory Testing), Application - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年生物製藥製造耗材測試市場規模為5,5875萬美元，預計2024年將達6,2,139萬美元，複合年成長率為11.71%，2030年將達12億美元，預計將達到1,354萬美元。

生物製藥製造耗材測試市場涵蓋確保生物製藥製造過程中使用的耗材的安全性、有效性和合規性所需的分析過程和材料。這些耗材包括培養基、試劑、過濾設備和其他直接影響藥品的關鍵零件，因此受到嚴格的品質保證。對消耗品測試的需求源於對生技藥品不斷成長的需求、日益嚴格的監管環境（需要嚴格的安全檢查）以及生物製藥製造技術的不斷創新。此類測試的應用範圍廣泛，包括細胞培養測試、生物加工、污染監測和品管，主要在製藥公司、實驗室和受託製造廠商。一次性技術的日益採用、生物技術投資的增加以及生技藥品和生物學名藥的不斷湧現推動了市場成長。然而，其局限性包括測試耗材的高成本、生技藥品製造的複雜性以及嚴格的監管合規要求。關鍵的成長機會在於自動化技術的進步，以簡化檢查流程，以及整合人工智慧進行預測分析，提高準確性和效率。永續實踐和環保測試耗材的引入進一步為降低成本和提高環境合規性提供了有利途徑。公司可以透過投資強力的研發來創新新的測試方法和材料來緩解挑戰。競爭格局仍然充滿活力，在即時檢測技術、提高靈敏度的檢測以及專為利基治療領域設計的客製化耗材方面具有巨大的創新潛力。企業必須優先考慮靈活應對監管變化，並與高科技公司建立合作夥伴關係，以利用數位技術的進步，從而應對這個不斷發展的市場的複雜性。隨著業界朝向精準醫療邁進，開發針對個人化醫療方案的耗材的針對性研究可以提供決定性的競爭優勢。

主要市場統計
基準年[2023] 55875萬美元
預測年份 [2024] 62139萬美元
預測年份 [2030] 1,213.54 百萬美元
複合年成長率（%） 11.71%

市場動態：針對快速發展的生物製藥製造消耗品測試市場揭示的關鍵市場洞察

生物製藥製造耗材測試市場正因供需的動態交互作用而轉變。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助消費行為及其對製造業的影響。

  • 市場促進因素
    • 生物製藥需求增加
    • 生物製藥耗材品質保證和安全的嚴格監管要求
  • 市場限制因素
    • 引進測試設備的高成本
  • 市場機會
    • 高效率生物製藥耗材檢測技術的進展
    • 各國生物製藥產業的擴張
  • 市場挑戰
    • 響應每個地區不斷變化的法規和標準

波特五力：引領生物製藥製造消耗品測試市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解生物製藥製造耗材測試市場的外部影響

外部宏觀環境因素在塑造生物製藥製造消耗品測試市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解生物製藥製造耗材測試市場的競爭狀況

生物製藥製造消耗品測試市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣生物製藥製造耗材測試市場供應商績效評估

FPNV定位矩陣是評估生物製藥製造耗材測試市場供應商的關鍵工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議，規劃生物製藥製造消耗品測試市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對生物製藥製造消耗品測試市場的策略分析至關重要。透過考慮關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監管核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 生物製藥需求增加
      • 生物製藥耗材品質保證和安全的嚴格監管要求
    • 抑制因素
      • 引進測試設備的高成本
    • 機會
      • 生物製藥耗材高效率檢測的技術進步
      • 生物製藥產業在整個經濟中持續擴張。
    • 任務
      • 適應不同地區不斷變化的法規和標準
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章生物製藥製造耗材測試市場：依產品類型

  • 消耗品
  • 裝置
  • 服務

第7章生物製藥製造耗材測試市場：按類型

  • 藥典測試
  • 自訂測試
  • 臨床檢查
    • 化學分析測試
    • 酵素測試
    • 穩定性測試
    • 無菌測試

第8章生物製藥製造耗材測試市場：依應用分類

  • 生物製藥製造
  • 品管與保證
  • 研究與開發

第9章 北美、南美洲生物製藥製造耗材檢測市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太生物製藥製造耗材檢測市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章 歐洲/中東/非洲生物製藥製造耗材檢測市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Agilent Technologies, Inc.
  • Alcami Corporation
  • Almac Group Limited
  • ALS Limited
  • ASTM International
  • Avance Biosciences, Inc.
  • Becton, Dickinson and Company
  • BioConvergence LLC
  • BioLife Solutions Inc.
  • bioMerieux SA
  • Boston Analytical, Inc.
  • Bureau Veritas SA
  • Catalent, Inc
  • Charles River Laboratories International, Inc.
  • Curia Global, Inc.
  • DEKRA SE
  • EM Topco Limited
  • Eurofins Scientific SE
  • Intertek Group PLC
  • Laboratory Corporation of America
  • LGM Pharma, LLC
  • Life Technologies（India）Pvt Ltd.
  • Merck KGaA
  • MISTRAS Group, Inc.
  • Neopharm Labs Inc.
  • Ortho-Clinical Diagnostics, Inc.
  • Pace Analytical Services, LLC
  • Pacific BioLabs, Inc.
  • ProtaGene, GmbH.
  • Sartorius AG
  • SGS SA
  • Sotera Health Company
  • STERIS PLC
  • Tentamus Group GmbH
  • Thermo Fisher Scientific Inc.
  • TUV SUD ELAB GmbH
  • WuXi AppTec, Inc.
Product Code: MRR-521BAA36EA7E

The Biopharmaceuticals Manufacturing Consumables Testing Market was valued at USD 558.75 million in 2023, expected to reach USD 621.39 million in 2024, and is projected to grow at a CAGR of 11.71%, to USD 1,213.54 million by 2030.

The biopharmaceuticals manufacturing consumables testing market encapsulates the analytical processes and materials required to ensure the safety, efficacy, and compliance of consumables used during the production of biologic drugs. These consumables include culture media, reagents, filtration devices, and other critical components that warrant stringent quality assurance due to their direct impact on drug products. The necessity of consumables testing arises from the growing demand for biologics, tighter regulatory landscapes demanding rigorous safety checks, and the continuous innovation in biopharmaceutical production techniques. The application of such testing is vast, encompassing cell culture testing, bioprocessing, contamination monitoring, and quality control, mainly in pharmaceutical companies, research laboratories, and contract manufacturing organizations. The market growth is bolstered by the increasing adoption of single-use technologies, rising biotech investments, and a burgeoning pipeline of biologics and biosimilars. However, some of the prevailing limitations include the high cost of consumables testing, the complexity involved in biologics manufacturing, and stringent regulatory compliance requirements. Key growth opportunities lie in the advancement of automation technologies, which streamline testing processes, and the integration of artificial intelligence for predictive analytics, enhancing accuracy and efficiency. Implementing sustainable practices and environmentally-friendly testing consumables further presents lucrative avenues for reducing costs and improving eco-compliance. Companies can mitigate challenges by investing in robust R&D to innovate new testing methodologies and materials. The competitive landscape remains dynamic, with significant innovation potential in real-time testing technologies, enhanced sensitivity assays, and customized consumables designed for niche therapeutic areas. Businesses must prioritize agile adaptation to regulatory changes and foster collaborations with tech firms to capitalize on digital advancements, thereby steering through the complexities of this evolving market. As the industry leans towards precision medicine, targeted research into developing consumables that cater specifically to personalized medicine protocols could offer a decisive competitive edge.

KEY MARKET STATISTICS
Base Year [2023] USD 558.75 million
Estimated Year [2024] USD 621.39 million
Forecast Year [2030] USD 1,213.54 million
CAGR (%) 11.71%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Biopharmaceuticals Manufacturing Consumables Testing Market

The Biopharmaceuticals Manufacturing Consumables Testing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing demand for biopharmaceutical products
    • Stringent regulatory requirements for quality assurance and safety of biopharmaceutical consumables
  • Market Restraints
    • High costs associated with deployment of testing equipment
  • Market Opportunities
    • Advancements in technologies for efficient biopharmaceutical consumables testing
    • Growing expansion of biopharmaceutical industry across economies
  • Market Challenges
    • Adapting to evolving regulations and standards across regions

Porter's Five Forces: A Strategic Tool for Navigating the Biopharmaceuticals Manufacturing Consumables Testing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Biopharmaceuticals Manufacturing Consumables Testing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Biopharmaceuticals Manufacturing Consumables Testing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Biopharmaceuticals Manufacturing Consumables Testing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Biopharmaceuticals Manufacturing Consumables Testing Market

A detailed market share analysis in the Biopharmaceuticals Manufacturing Consumables Testing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Biopharmaceuticals Manufacturing Consumables Testing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Biopharmaceuticals Manufacturing Consumables Testing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Biopharmaceuticals Manufacturing Consumables Testing Market

A strategic analysis of the Biopharmaceuticals Manufacturing Consumables Testing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Biopharmaceuticals Manufacturing Consumables Testing Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., Alcami Corporation, Almac Group Limited, ALS Limited, ASTM International, Avance Biosciences, Inc., Becton, Dickinson and Company, BioConvergence LLC, BioLife Solutions Inc., bioMerieux SA, Boston Analytical, Inc., Bureau Veritas SA, Catalent, Inc, Charles River Laboratories International, Inc., Curia Global, Inc., DEKRA SE, EM Topco Limited, Eurofins Scientific SE, Intertek Group PLC, Laboratory Corporation of America, LGM Pharma, LLC, Life Technologies (India) Pvt Ltd., Merck KGaA, MISTRAS Group, Inc., Neopharm Labs Inc., Ortho-Clinical Diagnostics, Inc., Pace Analytical Services, LLC, Pacific BioLabs, Inc., ProtaGene, GmbH., Sartorius AG, SGS SA, Sotera Health Company, STERIS PLC, Tentamus Group GmbH, Thermo Fisher Scientific Inc., TUV SUD ELAB GmbH, and WuXi AppTec, Inc..

Market Segmentation & Coverage

This research report categorizes the Biopharmaceuticals Manufacturing Consumables Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product Type, market is studied across Consumables, Instruments, and Services.
  • Based on Type, market is studied across Compendial Testing, Custom Testing, and Laboratory Testing. The Laboratory Testing is further studied across Chemical Analysis Testing, Enzyme Testing, Stability Testing, and Sterility Testing.
  • Based on Application, market is studied across Biopharmaceuticals Production, Quality Control & Assurance, and Research & Development.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing demand for biopharmaceutical products
      • 5.1.1.2. Stringent regulatory requirements for quality assurance and safety of biopharmaceutical consumables
    • 5.1.2. Restraints
      • 5.1.2.1. High costs associated with deployment of testing equipment
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancements in technologies for efficient biopharmaceutical consumables testing
      • 5.1.3.2. Growing expansion of biopharmaceutical industry across economies
    • 5.1.4. Challenges
      • 5.1.4.1. Adapting to evolving regulations and standards across regions
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Biopharmaceuticals Manufacturing Consumables Testing Market, by Product Type

  • 6.1. Introduction
  • 6.2. Consumables
  • 6.3. Instruments
  • 6.4. Services

7. Biopharmaceuticals Manufacturing Consumables Testing Market, by Type

  • 7.1. Introduction
  • 7.2. Compendial Testing
  • 7.3. Custom Testing
  • 7.4. Laboratory Testing
    • 7.4.1. Chemical Analysis Testing
    • 7.4.2. Enzyme Testing
    • 7.4.3. Stability Testing
    • 7.4.4. Sterility Testing

8. Biopharmaceuticals Manufacturing Consumables Testing Market, by Application

  • 8.1. Introduction
  • 8.2. Biopharmaceuticals Production
  • 8.3. Quality Control & Assurance
  • 8.4. Research & Development

9. Americas Biopharmaceuticals Manufacturing Consumables Testing Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Biopharmaceuticals Manufacturing Consumables Testing Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Biopharmaceuticals Manufacturing Consumables Testing Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Agilent Technologies, Inc.
  • 2. Alcami Corporation
  • 3. Almac Group Limited
  • 4. ALS Limited
  • 5. ASTM International
  • 6. Avance Biosciences, Inc.
  • 7. Becton, Dickinson and Company
  • 8. BioConvergence LLC
  • 9. BioLife Solutions Inc.
  • 10. bioMerieux SA
  • 11. Boston Analytical, Inc.
  • 12. Bureau Veritas SA
  • 13. Catalent, Inc
  • 14. Charles River Laboratories International, Inc.
  • 15. Curia Global, Inc.
  • 16. DEKRA SE
  • 17. EM Topco Limited
  • 18. Eurofins Scientific SE
  • 19. Intertek Group PLC
  • 20. Laboratory Corporation of America
  • 21. LGM Pharma, LLC
  • 22. Life Technologies (India) Pvt Ltd.
  • 23. Merck KGaA
  • 24. MISTRAS Group, Inc.
  • 25. Neopharm Labs Inc.
  • 26. Ortho-Clinical Diagnostics, Inc.
  • 27. Pace Analytical Services, LLC
  • 28. Pacific BioLabs, Inc.
  • 29. ProtaGene, GmbH.
  • 30. Sartorius AG
  • 31. SGS SA
  • 32. Sotera Health Company
  • 33. STERIS PLC
  • 34. Tentamus Group GmbH
  • 35. Thermo Fisher Scientific Inc.
  • 36. TUV SUD ELAB GmbH
  • 37. WuXi AppTec, Inc.

LIST OF FIGURES

  • FIGURE 1. BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET RESEARCH PROCESS
  • FIGURE 2. BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET DYNAMICS
  • TABLE 7. GLOBAL BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY COMPENDIAL TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY CUSTOM TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY LABORATORY TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY CHEMICAL ANALYSIS TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY ENZYME TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY STABILITY TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY STERILITY TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY BIOPHARMACEUTICALS PRODUCTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY QUALITY CONTROL & ASSURANCE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
  • TABLE 40. CANADA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. MEXICO BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
  • TABLE 44. MEXICO BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. UNITED STATES BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. ASIA-PACIFIC BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. AUSTRALIA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
  • TABLE 58. AUSTRALIA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. CHINA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
  • TABLE 62. CHINA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. INDIA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
  • TABLE 66. INDIA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. INDONESIA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
  • TABLE 70. INDONESIA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. JAPAN BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
  • TABLE 74. JAPAN BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. MALAYSIA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
  • TABLE 78. MALAYSIA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. PHILIPPINES BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
  • TABLE 82. PHILIPPINES BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. SINGAPORE BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
  • TABLE 86. SINGAPORE BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH KOREA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
  • TABLE 90. SOUTH KOREA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. TAIWAN BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
  • TABLE 94. TAIWAN BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. THAILAND BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
  • TABLE 98. THAILAND BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. VIETNAM BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
  • TABLE 102. VIETNAM BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. DENMARK BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
  • TABLE 111. DENMARK BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. EGYPT BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
  • TABLE 115. EGYPT BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. FINLAND BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
  • TABLE 119. FINLAND BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. FRANCE BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
  • TABLE 123. FRANCE BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. GERMANY BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
  • TABLE 127. GERMANY BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. ISRAEL BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
  • TABLE 131. ISRAEL BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. ITALY BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
  • TABLE 135. ITALY BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. NETHERLANDS BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
  • TABLE 139. NETHERLANDS BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. NIGERIA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
  • TABLE 143. NIGERIA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. NORWAY BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
  • TABLE 147. NORWAY BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. POLAND BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
  • TABLE 151. POLAND BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. QATAR BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
  • TABLE 155. QATAR BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 158. RUSSIA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
  • TABLE 159. RUSSIA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 162. SAUDI ARABIA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
  • TABLE 163. SAUDI ARABIA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH AFRICA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
  • TABLE 167. SOUTH AFRICA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. SPAIN BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
  • TABLE 171. SPAIN BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 174. SWEDEN BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
  • TABLE 175. SWEDEN BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 178. SWITZERLAND BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
  • TABLE 179. SWITZERLAND BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 182. TURKEY BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
  • TABLE 183. TURKEY BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED ARAB EMIRATES BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED ARAB EMIRATES BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED KINGDOM BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
  • TABLE 191. UNITED KINGDOM BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 192. BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 193. BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET, FPNV POSITIONING MATRIX, 2023